Biotech, Biosciences and Biopharmaceutical Companies in Maryland
20/20 GeneSystems Inc., Rockville MD: diagnostics, protein biomarkers for biodefense, cancer and autoimmune diseases, cancer treatment, oncology.

4Cyte Therapeutics, Baltimore, MD:An early-stage biotech company. The company’s mission is to discover, develop and market novel molecular diagnostic products that will revolutionize patient diagnosis and treatment.

A&G Pharmaceutica, Columbia, MD:A privately held theranostics company focused on the rapid development of monoclonal antibodies to disease-specific antigens as a basis for novel therapeutic and diagnostic products addressing a broad range of diseases.

ACell Inc., Jessop, MD: A regenerative medicine company that develops, manufactures, and markets products for medical and veterinary applications. Based on naturally occurring biological scaffolds, the tissue-engineered products produced by ACell change the fundamental healing response by encouraging the body's own regenerative capabilities to repair tissues and restore them to natural health.

Adlyfe Inc., Rockville, MD: Develop novel technologies for blood testing for early targets of amyloid diseases. Adlyfe is developing a novel test for the detection and amplification of amyloid proteins as early biomarkers of fatal brain diseases.

Advanced BioNutrition (ABN), Columbia, MD:Biotech company with existing proprietary products and a pipeline of new products and technologies that impact animal health and human nutrition.

Advanced BioScience Laboratories, Inc (ABL), Kensington, MD:Dedicated to conducting research and providing resources to develop and evaluate vaccines, therapeutics and diagnostics for infectious agents for the biomedical community. ABL is a highly skilled contract research organization (CRO) having extensive experience working with government, commercial, and other groups.

Advanced Biotechnologies, Inc., Columbia, MD: ABI specializes in the manufacture, development, and/or supply of critical, value-added products and services for the research, diagnosis, monitoring, and treatment of significant viral infectious diseases. ABI can support your production and research programs with:Viral Expertise:HIV, HTLV, EBV, CMV, HSV, VZV, HCV, SIV, Rubella, Chlamydia, Toxo ..Human Herpesviruses: HHV-6, HHV-7, HHV-8.

Akonni Biosystems, Fredericks, MD: Develops, manufactures and sells genetic-based diagnostic and disease surveillance solutions for both infectious and human health diseases.

Alba Therapeutics Corporation, Baltimore, MD: Biopharmaceutical Company focused on the discovery, development and commercialization of therapeutics to treat autoimmune, immune mediated and inflammatory diseases.

Alpha Biosciences, Baltimore, MD: Manufactures powered media for cell culture, plant tissue culture, custom media.

Cybrdi Inc., Frederick, Maryland:tissue array products, tissue microarrays, Immunohistochemistry, antibody.

Cynca Laboratories, Inc., Gaithersburg, MD: Our mission is to develop novel drugs against infectious and inflammatory diseases and develop the protein chip-based diagnosis and research tools.

CytImmune Sciences Inc., Rockville, MD:Developing a clinical pipeline of multifuncitonal, next-generation drug candidates binding know tumor-killing agents to its patented pegylated colloidal gold tumor targeting nanotechnology, to safely deliver increased drug levels at the site of disease and avoid affecting healthy organs.

Cyto Pulse Sciences, Inc., Glen Burnie, MD: The company is composed of a multidisciplinary staff of engineers and scientists. Cyto Pulse develops electric field based devices for use in vaccine delivery, vaccine production, personal vaccine production, gene therapy, and hybridoma production.

Dexall Biomedical Labs, Inc., Gaithersburg, MD:Developing and manufacturing novel immunodiagnostic products for physicians, clinical laboratories and hospitals. A decade later, Dexall has established itself as a high-tech biomedical company at the forefront of immunodiagnostic technology.

Diagnosoft's, Baltimore, MD: Mission is to develop methods and programs to help physicians better understand and assess the health of body organs in order to improve diagnosis, prognosis, and treatment. Diagnosoft is currently focused on implementing advanced methods for analyzing images of the heart obtained with Magnetic Resonance Imaging (MRI).

Digene Corporation, Gaithersburg, MD: Develops, manufactures and markets proprietary DNA and RNA testing systems for the screening, monitoring and diagnosis of human diseases -- with a focus on women's cancers and infectious diseases.The company's portfolio includes tests for human papillomavirus, and DNA tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea, as well as tests for blood viruses.

DNA Technology Inc., Gaithersburg, MD: DTI provides quality products and services to fellow researchers from pharmaceutical, biotechnology and biomedical research institutions. The company's mission is to develop innovative products and services that expedite and enhance scientific research and collaboration in genomics and proteomics.

Emergent BioSolutions, Rockville, MD:A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics, consisting of vaccines and therapeutics that induce or assist the body's immune system to prevent or treat disease. The company's biodefense business is focused on immunobiotics for use against biological agents that are potential weapons of bioterrorism. The company's commercial business is focused on development, manufacture and commercialization of immunobiotics for use against infectious diseases.

EntreMed, Inc., Rockville, MD: A clinical-stage pharmaceutical company developing therapeutic candidates mainly for the treatment of cancer and inflammation. The company's goal is to develop and commercialize new compounds based on its expertise in angiogenesis, cell cycle regulation and inflammation - processes vital to the treatment of cancer and other diseases such as rheumatoid arthritis

ExonHit Therapeutics Inc., Gaithersburg MD: A world-leading company in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. ExonHit's proprietary gene profiling technology DATAS™ is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company's strategy is to leverage on this valuable biological information in the fields of drug discovery, diagnostics and biochips.

Express Genomics Inc., Frederick, MD:Committed to providing innovative, high quality services for life science research. The company's initial offering includes cDNA library construction services. They have developed innovative technology to produce libraries containing more full-length cDNA inserts. Other services offered include libraries with an average insert size of ³3kb and libraries produced from small amounts of starting tissue and RNA.

FASgen, LLC., Baltimore, MD: Formed to access both therapeutic and diagnostic technologies based on the critical role played by fatty acid biosynthesis in health and disease. FASgen, LLC, holds exclusive licenses from Johns Hopkins University (JHU) to extensive patent estate as well as all subsequent improvements for therapeutic and diagnostic applications of the discoveries by the company's founders and their colleagues.

Functional Genetics Inc., Gaithersburg, MD:A privately owned biotechnology company engaged in the development of new therapeutics and diagnostic tools for the treatment of infectious disease, Alzheimer's disease, cancer and other human diseases.

Gene Logic Inc., Gaithersburg, MD: Provides support for pharmaceutical research and development with its extensive gene expression databases, efforts in toxicogenomics, bioinformatics expertise, preclinical testing services and drug repositioning approach.

GeneDx, Inc., Gaithersburg, MD: Specializes in genetic testing for rare hereditary disorders. The company's goal is to make clinical testing available to people with rare genetic conditions and their families.

GlycoTech, Gaithersburg, MD: Focuses on the biological functions and medical applications of glycoconjugates. The company has established its own research programs and has developed a large intellectual property portfolio, establishing libraries of rare carbohydrate reagents and technologies. They have maintained a corporate alliance with Novartis to develop small molecule mimics of carbohydrate ligands as potent antagonists for the aberrant extravasation of lymphocytes from the bloodstream during transplantation-induced reperfusion injury.

Hemagen  Diagnostic Inc., Columbia, MD: A biotechnology company that develops, manufactures, and markets proprietary medical diagnostic test kits used to aid in the diagnosis of certain autoimmune and infectious diseases.

Human Genome Sciences, Rockville, MD: HGS is a biopharmaceutical company discovering, developing, manufacturing and marketing drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. The company's clinical development pipeline includes drugs to treat hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS.

Igene Biotechnology, Inc., Columbia, MD:Focuses on the development, production and marketing of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, an essential nutrient used in many feed applications, as well as bulk nutraceutical grade natural astaxanthin for consumer ready health food supplements.

Imagilin Technology, Potomac, MD: A biotechnology company specializing in innovative product and technology development for animal/human health and nutrition. Our goal is to become one of the leading companies by offering living microorganisms as therapeutic/nutritional compounds for pets, farm animals and humans.

Innovative Biosensors Inc., College Park, MD: Developing and manufacturing rapid molecular detection technologies. The company's technology is expected to have broad applications in food testing, animal health and human health care, including drug discovery and development and disease diagnosis.

Integrated BioTherapeutics, Frederick, MD: An emerging research-based company dedicated to discovery of small molecules targeting various biothreat and emerging threat agents with a primary emphasis on rational, structure based approach. IBT also offers a range of products and services to the growing biodefense and infectious disease research community.

Intradigm Corporation, Rockville, MD: Develops targeted cancer therapeutics using in vivo RNAi technology for drug discovery and tissue-specific siRNA delivery.

Intralytix Inc., Baltimore, MD:A development stage biotechnology company focused on the production and marketing of products using bacteriophages to control bacterial pathogens in environmental, food processing, and medical settings.

Intronn Inc., Rockville, MD: Focused on RNA biology and therapeutics. The company utilizes its patented, broad-based technology to re-write the genetic message at the level of pre-messenger RNA. Gene reprogramming is achieved through trans-splicing, a naturally occurring process, and mediated by Intronn's patented RNA molecules.

Invitrogen Corporation, Frederick, MD: Provides essential life science technologies to academic and government research institutions, and pharmaceutical and biotech companies. The company's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology.

Juxtopia, Baltimore, MD:A biomedical and information technology (BIO-IT) company involved in the design and development of human performance products and services. Their technology is designed to integrate into one's daily routine and provide services to improve human health and learning for a lifetime.

KamTek Inc., Gaithersburg, MD:Mission is to convert newly evolved concepts of basic biological research and resulting technologies into widely used applications and marketable biotech products. The company extends these innovative products and specialized state-of-the-art services to biotech communities engaged in basic and applied research of medical, veterinary and agricultural importance. The focus is to promote investigations in the areas of Genomics, Proteomics and Glycomics using high throughput immuno- and DNA-diagnostic assays.

KPL Inc., Gaithersburg, MD: Develops, manufactures, and markets advanced protein detection reagents and systems for life Inc.,  scientists and bioindustrial customers worldwide. KPL has introduced over 600 reagents and complete assay kits for protein detection, purification and characterization that address the needs of cell biology, immunology, protein chemistry and molecular biology scientists.

Life Sciences Research Office Inc., Bethesda, MD:Provides scientific evaluation, advice and services to the government and private sectors.

LKC Technology Inc., Gaithersburg, MD:Tthe visual electrophysiology field with products used to diagnose a large number of ophthalmic conditions by measuring evoked potentials, including ERG, EOG, and VEP, dark adaptometry and more.

Lupin Pharmaceutical Inc., Baltimore, MD: A pharmaceutical company with strong research focus. The company is a leading global player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs (prils and statins) and has a notable presence in the areas of diabetology, NSAIDS and Asthma.

Macrogen  is a biotechnology company whose core businesses include DNA sequence analysis, manufacture of and experiment on biochips, and production of genetically engineered mice. The company is recognized for its genomic information analysis technology and provides sequencing services and expression profiling inCorp.orating Applied Biosystems' cutting edge technologies.

MacroGenics, Inc., Rockbille, MD: Developing immune-based products including monoclonal antibodies to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases and vaccines to prevent infections in healthy individuals.

Martek Biosciences Corporation, Columbia, MD:Develops DHA Omega-3 products that promote health and wellness through every stage of life. The company produces a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid) for use in foods and beverages, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula.

MaxCyte Inc., Gaithersburg, MD: A clinical-stage cell therapeutics company with a pipeline of proprietary and partnered drug candidates. Programs in development are based on the company's platform technology which breaks down the barriers to ex vivo cell loading and the manufacture of viral vectors. Their pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical candidates to treat a variety of diseases with unmet needs.

MedImmune Inc., Gaithersburg, MD: Focused on the areas of infectious diseases, cancer and inflammatory diseases. The company has four marketed products and an advancing pipeline of candidates designed to treat or prevent a number of debilitating or life-threatening diseases.

MetaMorphix Inc., Beltsville, MD: A privately held life sciences company using DNA to improve the global food supply and human health. The company is developing a pipeline of innovative products addressing all major livestock sectors including cattle, swine, poultry and aquaculture, as well as developing products that enhance the health of companion animals.

Metastatin  Pharmaceutical, Inc., Bethesda, MD: A development-stage biopharmaceutical company engaged in the development of cytostatic and anti-metastatic therapies for the management of cancer.

Minkon Biotechnology Inc., Gaithersburg, MD: A nutraceutical and pharmaceutical company focusing on the development of innovative food and health products for obesity prevention and treatment. It proposes to deliver reliable and efficient weight management products to an underserved market.

Mirari Biosciences, Inc., Columbia, MD:A start-up biotechnology company dedicated to improving healthcare by accelerating protein and gene discovery and detection.

MiTiHeart Corporation, Gaithersburg, MD: Prolong life and improve the quality of life of congestive heart failure patients by providing advanced state-of-the-art rotary blood pumps.

Nabi Pharmaceutical, Rockville, MD: Develops and markets products that fight serious medical conditions such as, gram-positive bacterial infections, hepatitis and transplant, kidney disease (nephrology), and nicotine addiction.

Naviscan PET System Inc., Rockville, MD: Designs and develops compact, high-resolution, positron emission tomography (PET) scanners that are intended to guide challenging radiological and surgical procedures.

Neuralstem Biopharmaceutical Inc., Rockville, MD:A biotherapeutics company utilizing its patented human neural stem cell technology to create cures for diseases of the CNS (central nervous system). The company’s technology allows for the isolation of CNS stem cells from tissue; the expansion in vitro of each cell up to a billion billion times, and the controlled differentiation of the cells into mature, physiologically relevant human neurons and glia.

NeuroLogic Inc., Rockville, MD: A drug discovery company focused on practical and innovative solutions for Central Nervous System (CNS) disorders and diseases affecting attention, learning, and memory as well as memory disorders such as Alzheimer's disease.

Neuronascent Inc., Clarksville, MD: A biotechnology company developing therapeutics for Alzheimer's disease, depression and stroke.

New Hope Pharmaceutical Inc., Bethesda, MD: A life sciences corporation established to commercialize a personalized therapeutic drug appraisal and bio-response platform for the treatment of cancer patients. The company anticipates that its technology will enhance the analysis and pre-treatment selection of existing drugs as well as find new applications and patient populations for existing therapies.

New Horizons Diagnostics Corporation, Columbia, MD: Specializes in manufacturing tests for the rapid detection of bacteria and toxins in human, environmental, surface, food, and water samples for use by municipal and corporate customers. Local and national agencies have turned to New Horizons for these needs.

Nutramax Laboratories, Edgewood, MD: A national company that researches, develops, and markets high quality products to support the active lifestyles of people and animals.

Nutricia International, Gaithersburg, MD: Specializes in the manufacture, marketing and distribution of medical foods and infant formulas for the dietary management of rare genetic, metabolic, allergic, gastrointestinal and neurological disorders.

OriGene Technology, Inc., Rockville, MD: Uses high-throughput gene cloning and gene expression profiling to develop commercially available products for pharmaceutical, biotechnology, and academic research and discovery applications. The company's flagship product is a searchable gene bank of over 30,000 human full-length cDNA clones from their collection and custom cloning program. These cDNAs are suitable for transfection and in vivo or direct in vitro expression.

Osiris Therapeitics Inc., Baltimore, MD:A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. The company currently markets and sells a product for regenerating bone in orthopedic indications. Their pipeline of internally developed biologic drug candidates under evaluation also includes medications for regenerating cartilage in the knee and repairing heart tissue following a heart attack.

Panacea Pharmaceutical Inc., Gaithersburg, MD: A privately-held biopharmaceutical company focused on the development and commercialization of therapeutics and diagnostics for diseases with substantial, unmet clinical needs, such as cancer, and acute and chronic neurodegenerative conditions, such as hypoxia-induced neurological insult, Parkinson’s Disease, and Alzheimer’s disease.

Panbio Limited, Columbia, MD: An Australian-based international diagnostics company which develops, manufactures and markets innovative diagnostic tests to aid in the diagnosis of infectious disease. The company is recognized as a world leader in tests used in the diagnosis of flavivirus and other arthropod-borne viruses.

PharmAthene Inc., Annapolis, MD: Engaged in the discovery and development of new human therapeutics and prophylactics for the treatment and prevention of morbidity and mortality from exposure to chemical and biological weapons. The company's goal is to develop a portfolio of products urgently needed by the U.S. government and its allies, with two products under development that are intended to provide protection from anthrax and chemical threats.

ProBiotix, Inc., Adelphi. MD: Research and development corporation, develops therapeutic drugs (treatment modalities) and diagnostic kits for neonatal diseases. It maintains critical links with specialists in infectious diseases, gastroenterology, and clinical chemistry, and consequently aims at developing novel anti-infective agents.

Ravgen, Columbia, MD: The goal at Ravgen is to revolutionize diagnosis and the treatment of human diseases through innovative technologies.

RegeneRx Biopharmaceutical Inc., Bethesda, MD:Focused on the discovery and development of novel molecules to accelerate tissue and organ repair. The company holds several patents and patent applications related to dermal, ocular, and internal wounds and tissue repair, cardiac and neurological injuries, and septic shock.

ReProtect Inc., Baltimore, MD: Focused on reducing unwanted pregnancies and sexually transmitted diseases (STDs), including HIV/AIDS, by providing effective and innovative products to protect the reproductive health of women and men throughout the world.

Revico Inc., Rockville, MD: Leveraging its understanding of FDA processes, western science and eastern traditional herbal medicine, has developed a platform and relationships which will provide the bridge necessary for the regulatory approval of botanical based pharmaceutical drugs. These drugs, derived from traditional herbal medicine, provide further ammunition in the fight against human diseases.

Rexahn Pharmaceutical, Inc., Rockville, MD: A biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, disorders of the central nervous system, and unmet medical needs.

Royer Biomedical Inc., Frederick, MD: Focused on developing, and selectively commercializing, localized, resorbable pharmaceutical products, for large underserved markets. The company's signature products are distinct technology platforms, each being bio-resorbable, and with the ability to provide a localized, controlled release of drugs over a broad range of time spans.

Sahajanand Biotech, Gaithersburg, MD: A drug discovery company that uses plant products as a source for its medicine. The company's goal is to reduce risk and treat high risk cancer individuals, those with inflammatory bowel disease and heavy metal overload (hemochromatosis, and Wilson Disease), and those with asbestos exposure.

Sanaria Inc., Rockville, MD: Goal is to develop and commercialize a non-replicating, metabolically active malaria sporozoite vaccine against Plasmodium falciparum, the malaria parasite responsible for more than 95% of malaria associated severe illness and death world-wide and the malaria parasite for which there is the most significant drug resistance.

Sequella Inc., Rockville, MD: Improved treatment paradigms for infectious diseases of epidemic potential. The company's initial focus has been on TB, but it is also identifying and developing drug candidates for SARS, candidiasis, ulcers (Helicobacter pylori), and other diseases with known or potential infectious etiology (Crohn’s disease).

Sequoia Pharmaceutical Inc., Gaithersburg, MD: Discovers and develops new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant infectious diseases.

Sigma-Tau Pharmaceutical Inc., Gaithersburg, MD: Dedicated to providing new therapies and new hope for patients with rare diseases. The company is commited to developing novel products and therapies for rare diseases and small numbers of patients.

Sleep Solutions, Pasadena, MD:  A privately held diagnostic service provider for home testing and evaluation of sleep-disordered breathing, which includes the diagnosis of Obstructive Sleep Apnea (OSA). The company offers physicians and their patients a fast, cost-effective, accurate and comfortable alternative to in-laboratory sleep studies. Utilizing proprietary sound analysis technology, their home-diagnostic system is delivered directly to the patient.

Sterilex  Corporation, Owings Mills, MD: Develops antimicrobial, anti-biofilm, and decontamination products for infection control, biofilm removal, biodecontamination, and chemical decontamination. The company's specialty biofilm-control biocides, disinfectants, and decontamination products are used in a variety of applications including human health, dental health, animal health, food processing, water care, industrial processing, and environmental remediation.

Sucampo Pharmaceutical Inc., Bethesda, MD: An emerging pharmaceutical company which focuses on the development and commercialization of drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.

SuperArray Biosciences Corp, Fredericks, MD:Develops and markets a wide range of innovative, pathway-focused life science research products. The company's three technology platforms are the foundation of its complementary toolset for systematic gene expression profiling (DNA microarrays), gene expression verification (PCR) and gene suppression (siRNA) on a pathway-by-pathway basis.

Supernus Pharmaceutical, Rockville, MD:A specialty pharmaceuticals company with a broad portfolio of proven and patented drug delivery technologies. Among its key technologies those for lead selection and formulation optimization, oral controlled release technologies, and reduced abuse potential technology.

Synthetic Genomics Inc., Rockville, MD: Develops and commercializes synthetic biology. The organization applies recent scientific advances, including newly discovered genetic sequences of novel photosynthetic and metabolic pathways, to execute various life functions within a synthetically devised organism. These breakthroughs could affect industries including energy, industrial organic compounds, pharmaceuticals, CO2 sequestration, fine chemicals, and environmental remediation.

Theradigm Inc., Baltimore, MD: Developing cell-based therapies for treatment of the central nervous system (CNS) disorders.

Therataxis, Baltimore, MD: Models brain transport processes and designs delivery methods for therapies. The company offers services in medical image analysis, biomedical simulations, therapy planning, and management of research.

TissueGene Inc., Gaithersburg, MD: A privately-held biopharmaceutical company developing a pipeline of regenerative medicine therapies in the field of cell-mediated therapy, and has several related products in development for the treatment of degenerative diseases.

Transgene, Kensington, MD: A biopharmaceutical company dedicated to the discovery and development of gene-based therapeutic vaccines and immunotherapy products for the treatment of cancer and infectious diseases.

Traxion Therapeutics, Catonsville, MD: A biotech company focused on the development of novel drugs for the treatment of intractable pain, specifically neuropathic pain.

TrimGen Corporation, Spacks, MD: A privately held company and subsidiary of Nihon Trim Co. Ltd. .The company's mission is to design and develop cutting edge molecular diagnostic and research tools. Its products are developed for a broad spectrum of applications including medical research, drug development, genetic screening, diagnosis, and drug treatment monitoring.

Trophogen, Inc., Rockville, MD: A biotechnology company founded in 2001 with series A funding from Toucan Capital, focusing on the development of high affinity glycoprotein hormone and related growth factor analogs for human and animal infertility as well as targeted therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers.

United Therapeutics, Silver Spring, MD: A biotechnology company focused on development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Vanda Pharmaceutical Inc., Rockville, MD: A biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. The company has candidate compounds in clinical trials for the treatment of schizophrenia, bipolar disorder, insomnia and depression, and excessive sleepiness.

VIRxSYS Corporation, Gaithersburg, MD: A private biotechnology company that develops therapies for serious diseases such as HIV, cancer and genetic diseases, utilizing its novel lentiviral vector platform.

Zylacta Corporation, Boyds, MD: A developmental stage company focused on antifibrotic therapy.

Center, Institutes, Park, Foundations, Organizations or associations of Biotech Related Industry in Maryland.

American Physiological Society, Bethesda, MD:

Frederick County Business & Employment Center, Frederick, MD: The mission of the Frederick County OED is to support, retain and foster the growth of existing businesses in the County and attract new businesses that bring career opportunities.

Maryland Dept. of Business and Economic Development, Baltimore, MD: DBED's mission is to attract new businesses, stimulate private investment and create jobs, encourage the expansion and retention of existing companies and provide businesses in Maryland with workforce training and financial assistance.

University of Maryland Biotechnology Institute, CARB, Rockville, MD: CARB is focused on advancing biotechnology by integrating molecular and biological science through research on biomolecular structure and function, biomolecular systems, and biometrology, and through the development of new technologies for measurement, analysis and design. CARB also provides training and fosters the development of biotechnology industry.